Skip to main content

Table 4 Multivariate Cox regression analysis including established prognostic parameters and the TFAP2D expression in all prostate cancers and in the subsets of ERG negative and ERG positive prostate cancers

From: Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion

Tumor subset

Scenario

n

p-value

preoperative PSA-Level

pT Stage

cT Stage

Gleason grade prostatectomy

Gleason grade biopsy

pN stage

R status

TFAP2D Expression

all cancers

1

10,827

<.0001*

<.0001*

–

<.0001*

–

<.0001*

<.0001*

0.2379

2

10,846

<.0001*

<.0001*

–

<.0001*

–

–

<.0001*

0.2712

3

10,692

<.0001*

–

<.0001*

<.0001*

–

–

–

0.0496*

4

9204

<.0001*

–

<.0001*

–

<.0001*

–

–

0.0007*

ERG-negative cancers

1

4327

<.0001*

<.0001*

–

<.0001*

–

0.8751

<.0001*

0.4114

2

4334

<.0001*

<.0001*

–

<.0001*

–

–

0.0040*

0.4285

3

4298

<.0001*

–

<.0001*

<.0001*

–

–

–

0.1722

4

4228

<.0001*

–

<.0001*

–

<.0001*

–

–

0.0007*

ERG- postive cancers

1

3429

<.0001*

<.0001*

–

<.0001*

–

<.0001*

0.0001*

0.61

2

3437

<.0001*

<.0001*

–

<.0001*

–

–

<.0001*

0.822

3

3383

<.0001*

–

<.0001*

<.0001*

–

–

–

0.8684

4

3327

<.0001*

–

<.0001*

–

<.0001*

–

–

0.2301

  1. Scenario 1 includes all postoperatively available parameters (pathological tumor (pT) stage, lymph node (pN), surgical margin (R) status, preoperative PSA value and Gleason grade obtained after the morphological evaluation of the entire resected prostate. Scenario 2 excluded the nodal status from analysis. Scenario 3 included preoperative PSA, clinical tumor (cT) stage and Gleason grade obtained on the prostatectomy specimen. In scenario 4, the preoperative Gleason grade obtained on the original biopsy was combined with preoperative PSA, and cT stage (* = significant)
Back to article page

Molecular Medicine

ISSN: 1528-3658